Boston Scientific (NYSE:BSX) is looking to join rhythm management rivals St. Jude Medical (NYSE:STJ) and Medtronic (NYSE:MDT) with its own truly leadless pacemaker, which is being developed to complement its S-ICD line, Dr. Ken Stein told MassDevice.com last week at the annual Heart Rhythm Society meeting in Boston.
Stein said development work on the as-yet-unnamed leadless pacer should be complete next year. It's being built "from the ground up" for 2-way communication with Boston's S-ICD devices, he told us.
Hey, check out all the research scientist jobs. Post your resume today!
Stein said development work on the as-yet-unnamed leadless pacer should be complete next year. It's being built "from the ground up" for 2-way communication with Boston's S-ICD devices, he told us.
Hey, check out all the research scientist jobs. Post your resume today!
